Discovery of important clue to the susceptibility of individuals to Crohn's disease

NewsGuard 100/100 Score

Crohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain and diarrhea, but the disorder is often associated with debilitating clinical complications.

Researchers from the University of Liege, Belgium, have now uncovered an important clue to the susceptibility of individuals to this disease.

In a genome-wide association study with more than 300,000 single nucleotide polymorphisms (SNPs) , DNA sequence variations occurring when a single nucleotide in the genome differs between members of a species , C'cile Libioulle et al. identified a new susceptibility locus for Crohn's disease. Their results are published online in the open-access journal PLoS Genetics.

Recent advances in SNP genotyping technology have allowed systematic association scanning of the entire genome for the detection of novel susceptibility loci , fixed positions on a chromosome, such as the position of a gene. Libioulle and colleagues applied this approach to Crohn's disease and identified the key locus on chromosome 5.

Individual susceptibility to many common diseases, including Crohn's disease, is determined by a combination of environmental and genetic factors and identifying these genetic risk factors is one of the most important objectives of modern medical genetics, potentially paving the way towards personalized medicine and drug target identification.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vaccines targeting chronic diseases show promise in combatting age-related conditions